152 related articles for article (PubMed ID: 15536075)
1. A novel peptide isolated from a phage display peptide library with trastuzumab can mimic antigen epitope of HER-2.
Jiang B; Liu W; Qu H; Meng L; Song S; Ouyang T; Shou C
J Biol Chem; 2005 Feb; 280(6):4656-62. PubMed ID: 15536075
[TBL] [Abstract][Full Text] [Related]
2. Novel engineered trastuzumab conformational epitopes demonstrate in vitro and in vivo antitumor properties against HER-2/neu.
Garrett JT; Rawale S; Allen SD; Phillips G; Forni G; Morris JC; Kaumaya PT
J Immunol; 2007 Jun; 178(11):7120-31. PubMed ID: 17513761
[TBL] [Abstract][Full Text] [Related]
3. Human recombinant B7-H3 expressed in E. coli enhances T lymphocyte proliferation and IL-10 secretion in vitro.
Zhang GB; Chen YJ; Shi Q; Ma HB; Ge Y; Wang Q; Jiang Z; Xu Y; Zhang XG
Acta Biochim Biophys Sin (Shanghai); 2004 Jun; 36(6):430-6. PubMed ID: 15188059
[TBL] [Abstract][Full Text] [Related]
4. Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu.
Riemer AB; Klinger M; Wagner S; Bernhaus A; Mazzucchelli L; Pehamberger H; Scheiner O; Zielinski CC; Jensen-Jarolim E
J Immunol; 2004 Jul; 173(1):394-401. PubMed ID: 15210798
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B.
Fuino L; Bali P; Wittmann S; Donapaty S; Guo F; Yamaguchi H; Wang HG; Atadja P; Bhalla K
Mol Cancer Ther; 2003 Oct; 2(10):971-84. PubMed ID: 14578462
[TBL] [Abstract][Full Text] [Related]
6. Induction of anti-EGFR immune response with mimotopes identified from a phage display peptide library by panitumumab.
Wang A; Cui M; Qu H; Di J; Wang Z; Xing J; Wu F; Wu W; Wang X; Shen L; Jiang B; Su X
Oncotarget; 2016 Nov; 7(46):75293-75306. PubMed ID: 27659529
[TBL] [Abstract][Full Text] [Related]
7. Production of mouse monoclonal antibodies against Helicobacter pylori Lpp20 and mapping the antigenic epitope by phage display library.
Li Y; Ning YS; Wang YD; Hong YH; Luo J; Dong WQ; Li M
J Immunol Methods; 2007 Aug; 325(1-2):1-8. PubMed ID: 17658545
[TBL] [Abstract][Full Text] [Related]
8. A novel peptide isolated from phage display peptides library recognized by an antibody against connective tissue growth factor (CTGF).
Liu N; Wu G; Li H; Li L; Xing H; Zhang C; Lu H
Int Immunopharmacol; 2009 Mar; 9(3):291-7. PubMed ID: 19103307
[TBL] [Abstract][Full Text] [Related]
9. Matching of trastuzumab (Herceptin) epitope mimics onto the surface of Her-2/neu--a new method of epitope definition.
Riemer AB; Kraml G; Scheiner O; Zielinski CC; Jensen-Jarolim E
Mol Immunol; 2005 May; 42(9):1121-4. PubMed ID: 15829301
[TBL] [Abstract][Full Text] [Related]
10. Treatment of HER-2/neu overexpressing breast cancer xenograft models with trastuzumab (Herceptin) and gefitinib (ZD1839): drug combination effects on tumor growth, HER-2/neu and epidermal growth factor receptor expression, and viable hypoxic cell fraction.
Warburton C; Dragowska WH; Gelmon K; Chia S; Yan H; Masin D; Denyssevych T; Wallis AE; Bally MB
Clin Cancer Res; 2004 Apr; 10(7):2512-24. PubMed ID: 15073131
[TBL] [Abstract][Full Text] [Related]
11. Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells.
Jamnani FR; Rahbarizadeh F; Shokrgozar MA; Ahmadvand D; Mahboudi F; Sharifzadeh Z
Exp Cell Res; 2012 Jun; 318(10):1112-24. PubMed ID: 22440788
[TBL] [Abstract][Full Text] [Related]
12. Identification of epitope regions recognized by tumor inhibitory and stimulatory anti-ErbB-2 monoclonal antibodies: implications for vaccine design.
Yip YL; Smith G; Koch J; Dübel S; Ward RL
J Immunol; 2001 Apr; 166(8):5271-8. PubMed ID: 11290813
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display library.
Vaisman N; Nissim A; Klapper LN; Tirosh B; Yarden Y; Sela M
Immunol Lett; 2000 Dec; 75(1):61-7. PubMed ID: 11163868
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neu.
Jasinska J; Wagner S; Radauer C; Sedivy R; Brodowicz T; Wiltschke C; Breiteneder H; Pehamberger H; Scheiner O; Wiedermann U; Zielinski CC
Int J Cancer; 2003 Dec; 107(6):976-83. PubMed ID: 14601058
[TBL] [Abstract][Full Text] [Related]
15. Trastuzumab (Herceptin) enhances class I-restricted antigen presentation recognized by HER-2/neu-specific T cytotoxic lymphocytes.
Kono K; Sato E; Naganuma H; Takahashi A; Mimura K; Nukui H; Fujii H
Clin Cancer Res; 2004 Apr; 10(7):2538-44. PubMed ID: 15073134
[TBL] [Abstract][Full Text] [Related]
16. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology].
Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of peptide mimics of blood group A antigen.
Tang Z; Wang L; Hu L; Li Y; Cui T; Xiong J; Dou L
J Huazhong Univ Sci Technolog Med Sci; 2008 Apr; 28(2):222-6. PubMed ID: 18481004
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120.
Königs C; Rowley MJ; Thompson P; Myers MA; Scealy M; Davies JM; Wu L; Dietrich U; Mackay CR; Mackay IR
Eur J Immunol; 2000 Apr; 30(4):1162-71. PubMed ID: 10760806
[TBL] [Abstract][Full Text] [Related]
19. Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumab.
Binder M; Vögtle FN; Michelfelder S; Müller F; Illerhaus G; Sundararajan S; Mertelsmann R; Trepel M
Cancer Res; 2007 Apr; 67(8):3518-23. PubMed ID: 17440057
[TBL] [Abstract][Full Text] [Related]
20. De novo design of peptide immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies.
Sundaram R; Lynch MP; Rawale SV; Sun Y; Kazanji M; Kaumaya PT
J Biol Chem; 2004 Jun; 279(23):24141-51. PubMed ID: 15060075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
